SEC Form 4 · accession 0001683168-17-000511
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Mar 3, 2017 | P | 696 | $6.78 | A | 11,736 | D | |
| Common Stock, par value $0.0001 per share | Mar 3, 2017 | P | 104 | $6.75 | A | 11,840 | D |
Table II — derivative securities
No Table II lines on this filing.